UnknownPhase 4

Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis

Egypt40 participantsStarted 2014-10

Plain-language summary

Hirschsprungs Associated Enterocolitis (HAEC) with incidence up to 30% postoperatively. The objective of the trial is to prevent postoperative HAEC by using Probiotics.

Who can participate

Age range6 Months – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hirschsprungs disease confirmed preoperative and postoperative specimen pathology Exclusion Criteria: * Other cases of Enterocolitis and constipation

What they're measuring

Prevention of Hirschsprung's associated enterocolitis (HAEC)

Timeframe: 6 months

Trial details

NCT IDNCT02343562

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12

Contact for this trial

Mahmoud MA Elfiky, M.D.

+201001557755 mfiky@kasralainy.edu.eg

View on ClinicalTrials.gov More Hirschsprung Disease trials